Porcine pepsin proteolysis of the hexapeptide LeuSer-p-nitro-Phe-Nle-Ala-Leu-OMe (where OMe ‫؍‬ methoxy and Nle ‫؍‬ norleucine) in the presence of dipeptide Leu-Leu synthesizes a new hexapeptide Leu-Ser-p-nitroPhe-Leu-Leu. Contrary to transpeptidation kinetics of other proteases, which depend upon an acyl-enzyme intermediate, the time course for pepsin-catalyzed transpeptidation displays a distinct lag before reaching a steady-state reaction velocity. Moreover, this lag is coupled to burst kinetics for the formation of proteolytic products, Leu-Ser-p-nitro-Phe and Nle-Ala-Leu-OMe. The lag requires that free Leu-Ser-p-nitro-Phe accumulate in the reaction medium during the lag phase and subsequently rebind for transpeptidation. Consistent with this dissociative kinetic mechanism are normal solvent isotope effects on formation of the proteolytic prod- Porcine pepsin has long been known to catalyze transpeptidation as well as proteolysis (1). By analogy with serine proteases, the following mechanism was envisioned,
peptide bond synthesis that has a potential for applications in biotechnology, it is here proposed that the energy necessary to drive peptide synthesis from free peptides comes from the sizable free energy drop associated with rehydration of the active site of pepsin in 55 M water.
Porcine pepsin has long been known to catalyze transpeptidation as well as proteolysis (1) . By analogy with serine proteases, the following mechanism was envisioned, E ϩ P 2 -P 1 º E ⅐ P 2 -P 1 O ¡
where E is the proteolytic enzyme, P 2 -P 1 is the polypeptide substrate with the scissile bond indicated by the hyphen, P 1 is the first peptide product released by proteolysis, P 2 is the second peptide product, N is an accepting peptide, and P 2 -N is the product of transpeptidation. P 2 -E is a covalent acyl-enzyme intermediate that is the key to the transpeptidation mechanism in serine proteases; the covalent bond can be transferred to a hydroxyl of water to form a free carboxyl group, or it can be transferred to the amino terminus of an accepting peptide to form a new peptide bond. This has long been thought to be the only possible mechanism for transpeptidation. For example, Kasche (2) has written emphatically: "Only proteases that form covalent acyl-enzyme intermediates can be used as catalysts in kinetically controlled 1 peptide synthesis." However, amid considerable controversy on how such an acyl-enzyme might form with aspartic proteases, various reports of transpeptidation yielding a product akin to N-P 1 appeared, which led to an alternative proposal of an amino-enzyme intermediate, E-P 1 (3), although no direct evidence was ever reported (4, 5) .
In opposition, James and Sielecki (6) argued from x-ray crystallographic data that the formation of a covalent intermediate is not likely to occur. More convincingly, Antonov et al. (7) reported the incorporation of 18 O from water into the scissle carbonyl of P 2 -N transpeptidation products, which requires that P 2 attain a free carboxyl at some intermediate stage. More recently, Hyland et al. (8) invoked an enzyme-bound amide hydrate adduct to explain similar 18 O exchange data with the human immunodeficiency virus aspartic protease. In addition, the relatively long incubation times 2 and low yields raised possibilities that the transpeptidation products of aspartic proteases may not be initial products but rather may arise from some secondary reaction or perhaps from a contaminating protease (6) .
Nevertheless, no alternative to a covalent mechanism was forthcoming, at least not until Rebholz and Northrop (9) found that pepsin obeys an iso-mechanism in which the enzyme finishes the chemistry of proteolysis in a different form than it began, and the isomerization back to the starting form is kinetically significant. This finding offered new possibilities for the chemical mechanism of transpeptidation by aspartic proteases. In an attempt to link the two, efforts were made to induce transpeptidation by manipulation of reaction conditions known to perturb the iso-mechanism. Solvent isotope effects were successful and are described below.
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MATERIALS AND METHODS
Leu-Ser-p-nitro-Phe-Nle 3 -Ala-Leu-OMe, Leu-Leu(-OH), Leu-Leu-NH 2 and Boc-Leu-Leu were purchased from Bachem and D 2 O from Cambridge Isotope Laboratories. Porcine pepsin was purchased from Sigma and purified on a Bio-Scale Q2 column (7 ϫ 52 mm) equilibrated with 0.1 M acetate buffer, pH 4.0. A 0 -1 M NaCl gradient was used with a flow rate of 2 ml/min. The purified enzyme was found to be homogenous by electrophoresis. Separation of reactant and product peptides was accomplished by reverse-phase HPLC using a -Bondapack C-18 HPLC column (3.9 ϫ 300 mm, particle size 10 m, pore size 125 Å) obtained from Millipore and a Hitachi L-6200 chromatographic system. Transpeptidation reaction mixtures were run at 25°C in 40 mM formate buffer pH or pD 4.0 and contained 1.15 nM pepsin, 1.2 mM Leu-Ser-pnitro-Phe-Nle-Ala-Leu-OMe and 6.43 mM acceptor peptide, Leu-Leu. During the course of the reaction, aliquot parts were taken at time intervals up to 16 h and assayed by HPLC reverse-phase chromatography, monitored at either 214 or 254 nm, using a 0 -70% acetonitrile gradient at a flow rate of 5 ml/min.
Electrospray ionization mass spectra were collected in the positiveion mode using a VG Platform II mass spectrometer (VG Analytical, Manchester, UK) and a methanol mobile phase. Samples were dissolved in 98% formic acid and diluted methanol to 0.1 mM. The diluted sample was pumped into the mass spectrometer source (60°C) at a flow rate of 0.01 ml/min. Progress curves of the formation of peptide products were fitted to the following equation describing a hysteretic burst or lag as described by Frieden (10) using a BASIC computer program employing the nonlinear regression routine of Duggleby (11),
where P is the amount of product formed, i is the intercept (subtracted from the progress curves below), v o is the initial velocity at time zero, v s is the steady-state velocity, k is the rate constant controlling the hysteretic transition between v o and v s , and t is the elapsed time.
RESULTS
Fig . 1 shows the HPLC optical absorption elution profiles, which document a transpeptidation reaction between Leu-Serp-nitro-Phe-Nle-Ala-Leu-OMe and Leu-Leu in the presence of porcine pepsin. Peak 3 could not be detected in the absence of either peptide. A similar peak was observed with Leu-Leu-NH 2 as the accepting peptide, but not with Boc-Leu-Leu, which suggests a P 2 -N transpeptidation product. The product was more absorptive at 254 nm than at 214 nm, which is further suggestive of P 2 -N, because the P 1 product, Nle-Ala-Leu-OMe identified as peak 5, is transparent at the higher wavelength. A transpeptidation product of P 2 -N in the form of Leu-Ser-pnitro-Phe-Leu-Leu was confirmed by mass spectrometry of material from peak 3, giving a measured mass of 636.1 daltons (data not shown) as compared with a calculated value of 636.
The increase in areas of peak 3 in profiles B-D of Fig. 1 and other profiles not shown were converted to peptide concentration and are plotted as a function of time as shown in Fig. 2 . A distinct lag is apparent in Fig. 2A , the progress of the formation of the transpeptidation product that is even more pronounced in D 2 O, leading to a steady-state velocity that is more than twice as fast in D 2 O than in H 2 O and generating an inverse solvent isotope effect. Coincident with the lag is a burst in the progress of formation of the proteolytic products Nle-Ala-LeuOMe and Leu-Ser-p-nitro-Phe shown in Fig. 2 , B and C, respectively. These bursts are not seen in the absence of the accepting peptide or in the presence of Boc-Leu-Leu and are less pronounced in D 2 O. The progress curves in both Fig. 2B and 2C develop more slowly in D 2 O than in H 2 O, thus generating normal solvent isotope effects, but the effects are not the same for both products.
FIG. 1. HPLC elution profiles of transpeptidation incubations.
Absorbencies in profile A were monitored at 214 nM at 16 h; profiles B, C, and D were monitored at 254 nm at 4, 8, and 12 h, respectively, on a different scale. Peaks were identified as: 1, solvent front; 2, Leu-Leu; 3, Leu-Ser-p-nitro-Phe-Leu-Leu; 4, Leu-Ser-p-nitro-Phe; 5, Nle-AlaLeu-OMe; 6, Leu-Ser-p-nitro-Phe-Nle-Ala-Leu-OMe; unidentified peaks preceding 6 were impurities. 
DISCUSSION
The lag in the transpeptidation reaction is consistent with a dissociation of Leu-Ser-p-nitro-Phe from pepsin followed by a dependence upon the accumulation of this proteolytic product in the reaction medium. In contrast, Kasche (2) describes the progress curves of transpeptidation by covalent acyl-enzyme intermediates as having a maximal rate at time 0 and progressively decreasing rates as products accumulate. The burst kinetics in the formation of proteolytic products similarly support a dissociative mechanism and are not consistent with any dependence upon an enzyme-bound product mechanism, covalent or otherwise. The correlation between lags and bursts shows a linkage between proteolysis and transpeptidation that effectively rules out participation of a contaminant enzyme or of a putative secondary reaction mechanism.
The linkage between lags and bursts is dramatically evidenced in the numerical symmetry of the data in Table I . The inverse isotope effect on transpeptidation rules out the traditional interpretation (that is, effects originating in a substrate bond-breaking chemical step, which are normal) and instead requires that the effect originate from some change in equilibria. Equilibrium isotope effects, termed "fractionation factors" by Kresge (12) , have a long history and are rarely this small. Moreover, the linkage to normal isotope effects with a reciprocal magnitude is inconsistent with the origins described by Kresge. Instead, the mix of solvent isotope effects in Table I constitutes a new type of isotope effect, with a kinetic origin but with similarities to fractionation factors; it arises from a change in the quasi-equilibrium distribution of intermediate enzyme forms associated with the steady-state phase of enzymatic catalysis. The diversion of the Leu-Ser-p-nitro-Phe away from proteolytic product accumulation and toward transpeptidation places the isotopically sensitive step "downstream" from the steps participating in transpeptidation. It was previously reported that solvent isotope effects were observed on V max but not on V max /K m (9), which only placed the isotopically sensitive step downstream from the first irreversible step, the release of the first product during initial velocity measurements. A reaction mechanism consistent with all solvent isotope effects is shown in Scheme II,
where E ϭ (H 2 O)-pepsin COO-COOH , F ϭ pepsin COOH COO-, and G ϭ pepsin COO-COOH . The nomenclature is similar to that used in Scheme I, but Leu-Ser-p-nitro-Phe is considered the second product, P 2 , only by analogy. Because both products dissociate from the enzyme, the order of their dissociation is unknown and not designated. The dissociation of products is shown as being irreversible, because initially the concentration of products is zero. The starting form of enzyme, E, has water tightly bound at the active site and the two aspartic carboxyl groups are in the proper protonation state for catalysis. The product form of enzyme, F, is dehydrated, and the carboxyls are in the reverse state of protonation, having acted as a general acid and a general base during catalysis. Converting F to G, with the proper protonation, is the isotopically sensitive step. The final step in proteolysis is re-hydration of the re-protonated enzyme, shown here as being irreversible, because in 55 M H 2 O, the equilibrium would be very far to the right. F can bind the accepting peptide, N, and after sufficient product has accumulated, F⅐N can bind P 2 . Further support for this mechanism can be found in the solvent isotope effects associated with the onset of inhibition of pepsin by pepstatin (13) , which also placed the isotopically sensitive step after the release of both products but before rehydration, with rapid binding of pepstatin to the G form of enzyme. In the new isotope effect, the analogy to the fractionation factor is actually a D 2 O-dependent diversion of F away from the upper rehydration pathway back to E, toward the lower transpeptidation pathway. 4 By this analogy, the inverse isotope effect on transpeptidation might be termed a "diversion factor." Although new to isotope effects, these reaction kinetics themselves have been described before in the form of the induced transport kinetics described by Britton (16) and used to unequivocally establish iso-mechanisms. During induced transport, an F form of enzyme reacts with an isotopically labeled acceptor that is chemically identical with one product. For example, in the presence of an excess of H 12 CO 3 Ϫ , bovine carbonic anhydrase type II reacts with 13 CO 2 and catalyzes the synthesis of H 13 CO 3 Ϫ (17). Curiously, pepsin and carbonic anhydrase have similar isomerization segments in that both involve an intramolecular proton transfer step that is isotopically sensitive plus a step involving the binding of a molecule of water. The chemical mechanism for pepsin is postulated to involve general acid catalysis by the carboxyl group of Asp-215, and general base catalysis by the carboxyl group of Asp-32 (5), which leaves the active site groups in the reverse state of protonation. Reprotonation of the carboxyls in a partially ratelimiting isomerization step of free enzyme is reminiscent of the iso-mechanism of proline racemase (14) in which two thiols in opposite states of protonation act as a general acid and general base. The racemization of proline, however, has an equilibrium constant of one and the reaction runs freely in both directions. For pepsin, the reverse reaction (transpeptidation) must be initiated before the drop in free energy associated with the overall proteolysis is expressed. Hence, the origin of the free energy needed to synthesize a peptide bond between free peptides is the tightness of the binding of a water molecule in the active site. As illustrated in Fig. 3 , the energy level of enzyme form F and enzyme with a reactant containing an intact peptide bond, such as ES, must be fairly equivalent, but the energy levels of the hydrated and dehydrated forms of free enzyme, E and G, respectively, must differ, with the hydrated E form lying much lower than G in 55 M H 2 O. It follows, that a similar negative free energy must be associated with the enzymatic removal of a water molecule from between neighboring carboxyl and amino groups in the formation of a peptide bond as an alternative pathway for hydrating the F form of enzyme and converting it back to E (see Equation 2 ).
For this mechanism to account for the kinetics and solvent isotope effects of transpeptidation, it must be further postulated that the conversion of F to G be accompanied by a conformational change, which allows water to enter the active site. Hydration of the product form of enzyme, F, must await reprotonation, which is slower in D 2 O and which in turn raises the steady-state concentration of F. The increase in [F] drives the increase in the rate of transpeptidation in D 2 O. This change in [F] is the origin of the inverse solvent isotope effect and why it is analogous to an equilibrium isotope effect. Pepsin-catalyzed transpeptidation is extremely sensitive to pH and other reactant conditions. For example, although peptide bond cleavage of slow substrates has a maximum rate at pH 3.5 (15) , and therefore one might expect that the isomerization of free enzyme would be most rate-limiting, the transpeptidation described below could barely be detected at this pH. Equally confusing, at pH 5, where the chemical step is not at all favorable and therefore significantly rate-limiting, the original solvent isotope effect suggesting an iso-mechanism was first measured; nevertheless, transpeptidation was elusive and difficult to repeat at pH 5. But at pH 4, enzyme plus Leu-Ser-p-nitro-Phe-Nle-Ala-Leu-OMe and Leu-Leu consistently generate a large and reproducible peak on HPLC analysis, evidenced by the precision of the progress curves of Fig. 2 . The sketchy and uncertain history of transpeptidation by aspartic proteases can now be appreciated with a more sympathetic understanding, especially for studies employing slow substrates, which we can now see as being very poor catalysts for transpeptidation because of the very low levels of F that would be present when the chemical segment is slow and ratelimiting. These reaction conditions may be exploited to develop practical methods of synthesizing specific peptide bonds. Kasche (2) noted the necessity for operating at a pH between the pK values of the carboxyl and amino groups to be joined together, that in many cases this occurs at acidic values of pH where many enzymes are unstable, and that "until better enzymes are found, this equilibrium-controlled synthesis is of no practical interest." Pepsin is a "better enzyme" with both stability and catalytic activity at acidic pH, plus a kinetic mechanism ideally suited to join free carboxyl and amino groups in peptide bonds provided one drives the peptide synthesis kinetically with a sacrificial peptide that is a fast enough substrate to ensure that most of the pepsin is in the F form. Enzyme is saturated with substrate S, and the reaction effectively begins with ES. The first transition state represents peptide bond cleavage and is estimated to be much lower than the transition state for the release of products because of the lack of an isotope effect on V/K. The isotopically sensitive reprotonation step is between enzyme forms F and G. The large negative free energy for proteolysis is hypothesized to be focused on the rehydration of G to form E, the starting form of enzyme, which can then bind another molecule of substrate.
